• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估罕见遗传变异,以鉴定神经纤维瘤病 1 患者神经表现的候选修饰基因。

Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients.

机构信息

Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

出版信息

Genes (Basel). 2022 Nov 26;13(12):2218. doi: 10.3390/genes13122218.

DOI:10.3390/genes13122218
PMID:36553485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9778305/
Abstract

Neurological phenotypes such as intellectual disability occur in almost half of patients with neurofibromatosis 1 (NF1). Current genotype-phenotype studies have failed to reveal the mechanism underlying this clinical variability. Despite the presence of pathogenic variants of NF1, modifier genes likely determine the occurrence and severity of neurological phenotypes. Exome sequencing data were used to identify genetic variants in 13 NF1 patients and 457 healthy controls, and this information was used to identify candidate modifier genes underlying neurological phenotypes based on an optimal sequence kernel association test. Thirty-six genes were identified as significant modifying factors in patients with neurological phenotypes and all are highly expressed in the nervous system. A review of the literature confirmed that 19 genes including , , and are clearly associated with the alteration of neurological functioning and development. Our study revealed the enrichment of rare variants of 19 genes closely related to neurological development and functioning in NF1 patients with neurological phenotypes, indicating possible modifier genes and variants affecting neurodevelopment. Further studies on rare genetic variants of candidate modifier genes may help explain the clinical heterogeneity of NF1.

摘要

神经纤维瘤病 1 型(NF1)患者几乎有一半会出现智力残疾等神经表型。目前的基因型-表型研究未能揭示这种临床变异性的机制。尽管存在 NF1 的致病性变异,但修饰基因可能决定了神经表型的发生和严重程度。使用外显子组测序数据,对 13 名 NF1 患者和 457 名健康对照者的遗传变异进行了鉴定,并基于最佳序列核关联测试,利用这些信息鉴定了神经表型潜在的候选修饰基因。鉴定出 36 个与神经表型相关的基因作为显著的修饰因子,所有这些基因在神经系统中均有高度表达。文献综述证实,包括 、 和 在内的 19 个基因显然与神经功能和发育的改变有关。我们的研究揭示了 NF1 患者神经表型中与神经发育和功能密切相关的 19 个基因的罕见变异富集,表明可能存在影响神经发育的修饰基因和变异。对候选修饰基因罕见遗传变异的进一步研究,可能有助于解释 NF1 的临床异质性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7b/9778305/ee4d0e38a6b1/genes-13-02218-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7b/9778305/0494a71873b9/genes-13-02218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7b/9778305/e4ff7e5bcc01/genes-13-02218-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7b/9778305/ee4d0e38a6b1/genes-13-02218-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7b/9778305/0494a71873b9/genes-13-02218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7b/9778305/e4ff7e5bcc01/genes-13-02218-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7b/9778305/ee4d0e38a6b1/genes-13-02218-g003.jpg

相似文献

1
Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients.评估罕见遗传变异,以鉴定神经纤维瘤病 1 患者神经表现的候选修饰基因。
Genes (Basel). 2022 Nov 26;13(12):2218. doi: 10.3390/genes13122218.
2
Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes.1型神经纤维瘤病临床表型变异中可能的修饰基因。
J Neurogenet. 2018 Mar-Jun;32(2):65-77. doi: 10.1080/01677063.2018.1456538. Epub 2018 Apr 12.
3
NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.NF1 患者错义变异预测 ATM 在调节神经纤维瘤起始中的作用。
Acta Neuropathol. 2020 Jan;139(1):157-174. doi: 10.1007/s00401-019-02086-w. Epub 2019 Oct 29.
4
Neurofibromatosis type 1: from genotype to phenotype.神经纤维瘤病 1 型:从基因型到表型。
J Med Genet. 2012 Aug;49(8):483-9. doi: 10.1136/jmedgenet-2012-100978.
5
Clinical Presentation and Novel Pathogenic Variants among 68 Chinese Neurofibromatosis 1 Children.68 例中国神经纤维瘤病 1 型患儿的临床表现及新型致病突变。
Genes (Basel). 2019 Oct 26;10(11):847. doi: 10.3390/genes10110847.
6
Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy.全外显子组测序揭示了一种可能致病的NF1变异,该变异导致1型神经纤维瘤病和致心律失常性心肌病。
BMC Cardiovasc Disord. 2024 Apr 23;24(1):220. doi: 10.1186/s12872-024-03878-z.
7
Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients.基于胚系 NF1 变异体鉴定和 NF1 及非 NF1 先天性胫骨假关节的特征:75 例患者的遗传和临床分析。
Orphanet J Rare Dis. 2019 Sep 18;14(1):221. doi: 10.1186/s13023-019-1196-0.
8
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1.1 型神经纤维瘤病患者十二指肠神经内分泌肿瘤的全外显子组测序。
Mod Pathol. 2018 Oct;31(10):1532-1538. doi: 10.1038/s41379-018-0082-y. Epub 2018 May 30.
9
Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India.经济有效的全外显子组测序在印度查谟和克什米尔的一个家庭中发现导致 1 型神经纤维瘤病的致病性变异。
Sci Rep. 2023 May 15;13(1):7852. doi: 10.1038/s41598-023-34941-y.
10
Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution.
Eur J Paediatr Neurol. 2023 Mar;43:52-61. doi: 10.1016/j.ejpn.2023.02.006. Epub 2023 Mar 5.

本文引用的文献

1
Identifying Rare Genetic Variants of Immune Mediators as Risk Factors for Autism Spectrum Disorder.鉴定免疫介质罕见遗传变异作为自闭症谱系障碍的风险因素。
Genes (Basel). 2022 Jun 20;13(6):1098. doi: 10.3390/genes13061098.
2
Neurological manifestations of neurofibromatosis type 1: our experience.神经纤维瘤病 1 型的神经学表现:我们的经验。
Neurologia (Engl Ed). 2022 Jun;37(5):325-333. doi: 10.1016/j.nrleng.2019.05.008. Epub 2021 May 26.
3
Rare Modifier Variants Alter the Severity of Cardiovascular Disease in Pseudoxanthoma Elasticum: Identification of Novel Candidate Modifier Genes and Disease Pathways Through Mixture of Effects Analysis.
罕见修饰变异改变弹性假黄瘤心血管疾病的严重程度:通过效应混合分析鉴定新型候选修饰基因和疾病途径。
Front Cell Dev Biol. 2021 Jun 8;9:612581. doi: 10.3389/fcell.2021.612581. eCollection 2021.
4
Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation.在脆性 X 前突变的高风险遗传背景下,鉴定原发性卵巢功能不全的易感基因。
Fertil Steril. 2021 Sep;116(3):843-854. doi: 10.1016/j.fertnstert.2021.04.021. Epub 2021 May 18.
5
An adult Chinese patient with developmental delay with short stature, dysmorphic features, and sparse hair (Loucks-Innes syndrome).一名患有发育迟缓、身材矮小、容貌异常和稀疏毛发的成年中国患者(卢克斯-因内斯综合征)。
Am J Med Genet A. 2021 Jun;185(6):1925-1931. doi: 10.1002/ajmg.a.62164. Epub 2021 Mar 11.
6
Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1.神经纤维瘤病 1 型中异构体特异性 NF1 mRNA 水平与疾病严重程度相关。
Orphanet J Rare Dis. 2019 Nov 15;14(1):261. doi: 10.1186/s13023-019-1223-1.
7
The reactome pathway knowledgebase.Reactome 通路知识库。
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503. doi: 10.1093/nar/gkz1031.
8
Genetic modifiers and non-Mendelian aspects of CMT.CMT 的遗传修饰因子和非孟德尔遗传方面。
Brain Res. 2020 Jan 1;1726:146459. doi: 10.1016/j.brainres.2019.146459. Epub 2019 Sep 13.
9
β-Carotene 15,15'-oxygenase inhibits cancer cell stemness and metastasis by regulating differentiation-related miRNAs in human neuroblastoma.β-胡萝卜素 15,15'-加氧酶通过调节人神经母细胞瘤中与分化相关的 miRNAs 抑制肿瘤干细胞干性和转移。
J Nutr Biochem. 2019 Jul;69:31-43. doi: 10.1016/j.jnutbio.2019.03.010. Epub 2019 Mar 28.
10
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.